Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ketamine in Acute Brain Injury Patients. — Stella

Home/Brain Injuries, Traumatic/Ketamine in Acute Brain Injury Patients.

View on ClinicalTrials.gov

Recruiting

Back to Brain Injuries, Traumatic trials

Ketamine in Acute Brain Injury Patients.

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(8 sites)

Belgium

Imelda Bonheiden, Bonheiden

AZ Sint-Jan, Bruges

Jessa Ziekenhuis, Hasselt

UZLeuven, Leuven

CHR de la Citadelle Liège, Liège

CHU de Liège, Liège

AZ Delta, Roeselare

AZ Turnhout, Turnhout

Key details

Phase

Post-approval study

Sponsor

Geert Meyfroidt, MD, PhD

Collaborators

University of Liege, Centre Hospitalier Régional de la Citadelle

Enrollment target

~100 participants

Started

September 2021

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.